Similar articles

• Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin.

  Chen L, Mai W, Chen M, Hu J, Zhuo Z, Lei X, Deng L, Liu J, Yao N, Huang M, Peng Y, Ye W, Zhang D. Chen L, et al. Pharmacol Res. 2017 Sep;123:130-142. doi: 10.1016/j.phrs.2017.07.009. Epub 2017 Jul 14. Pharmacol Res. 2017. PMID: 28712972
• FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells.

  Liu H, Yin J, Wang H, Jiang G, Deng M, Zhang G, Bu X, Cai S, Du J, He Z. Liu H, et al. Cell Signal. 2015 Mar;27(3):510-8. doi: 10.1016/j.cellsig.2015.01.001. Epub 2015 Jan 8. Cell Signal. 2015. PMID: 25578861
• β-ionone Inhibits Epithelial-Mesenchymal Transition (EMT) in Prostate Cancer Cells by Negatively Regulating the Wnt/β-Catenin Pathway.

  Fang Q, Que T, Liu B, Dan W, Wei Y, Ren B, Fan Y, Hou T, Zeng J. Fang Q, et al. Front Biosci (Landmark Ed). 2022 Dec 28;27(12):335. doi: 10.31083/j.fbl2712335. Front Biosci (Landmark Ed). 2022. PMID: 36624947
• Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process.

  Lee HM, Hwang KA, Choi KC. Lee HM, et al. Mol Cell Endocrinol. 2017 Dec 5;457:103-113. doi: 10.1016/j.mce.2016.12.026. Epub 2016 Dec 29. Mol Cell Endocrinol. 2017. PMID: 28042023 Review.
• Cell death under epithelial-mesenchymal transition control in prostate cancer therapeutic response.

  Begemann D, Anastos H, Kyprianou N. Begemann D, et al. Int J Urol. 2018 Apr;25(4):318-326. doi: 10.1111/iju.13505. Epub 2018 Jan 17. Int J Urol. 2018. PMID: 29345000 Review.